Aurora Cannabis Inc. · NASDAQ (us_market)
Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2025-12-17$5.57 RISE2026-03-30$3.08 PEAK2026-04-22$3.80 126d | -44.7% 103d | Missed | Missed | — | — | +23.4% 23d | Missed |
DROP2025-09-29$6.23 RISE2026-02-05$3.31 PEAK2026-02-26$3.89 150d | -46.9% 129d | Missed | Missed | — | — | +17.5% 21d | Missed |
DROP2025-09-29$6.23 RISE2025-11-20$4.08 PEAK2025-12-17$5.57 79d | -34.5% 52d | Missed | Missed | — | — | +36.5% 27d | Missed |
DROP2025-06-16$6.15 RISE2025-08-07$4.21 PEAK2025-09-29$6.23 105d | -31.5% 52d | Missed | Missed | — | — | +48.0% 53d | Missed |
DROP2025-02-13$6.62 RISE2025-06-23$3.91 PEAK2025-08-28$5.62 196d | -40.9% 130d | Missed | Missed | — | — | +43.7% 66d | Missed |
DROP2025-02-13$6.62 RISE2025-04-08$3.88 PEAK2025-06-16$6.15 123d | -41.4% 54d | Missed | Missed | — | — | +58.5% 69d | Missed |
DROP2024-11-05$6.11 RISE2025-02-03$3.46 PEAK2025-02-13$6.62 100d | -43.4% 90d | Missed | Missed | — | — | +91.3% 10d | Missed |
DROP2024-08-08$7.05 RISE2024-11-19$4.18 PEAK2025-02-13$6.62 189d | -40.7% 103d | Missed | Missed | — | — | +58.4% 86d | Missed |
DROP2024-04-30$9.23 RISE2024-07-02$4.52 PEAK2024-08-08$7.05 100d | -51.0% 63d | Missed | Missed | — | — | +56.0% 37d | Missed |
DROP2023-12-04$5.20 RISE2024-03-14$2.89 PEAK2024-04-30$9.23 148d | -44.4% 101d | Missed | Missed | — | — | +219.4% 47d | Missed |
DROP2023-09-15$9.83 RISE2023-10-26$4.21 PEAK2023-12-04$5.20 80d | -57.2% 41d | Missed | Missed | — | — | +23.5% 39d | Missed |
DROP2023-05-19$6.68 RISE2023-08-28$4.40 PEAK2023-09-15$9.83 119d | -34.1% 101d | Missed | Missed | — | — | +123.4% 18d | Missed |
DROP2023-02-02$11.30 RISE2023-06-01$5.04 PEAK2023-06-22$6.17 140d | -55.4% 119d | Missed | Missed | — | — | +22.4% 21d | Missed |
DROP2022-08-25$17.00 RISE2022-12-28$8.47 PEAK2023-02-02$11.30 161d | -50.2% 125d | Missed | Missed | — | — | +33.4% 36d | Missed |
DROP2022-08-15$18.90 RISE2022-10-24$10.40 PEAK2022-11-15$15.40 92d | -45.0% 70d | Missed | Missed | — | — | +48.1% 22d | Missed |
1–15 / 26 1 / 2 | |||||||
No scored news yet for a sentiment trend.
https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec
Canopy Growth gains attention as marijuana reclassification boosts cannabis sentiment, but margin pressure and execution risks persist.
This certification gives Aurora the exclusive rights to grow, propagate, and sell finished products produced from these varieties.The two protected cultivars, SOT20R07-007 (known as Farm Gas™) and SOT20R07-005
SNDL faces pressure after Q1 results show falling sales, weak cannabis demand, and margin strain, raising concerns about growth in a saturated Canadian market.
Key Takeaways; Cannabis Sector SNDL Reported “Particularly Challenging” First Quarter 2026 Financial and Operational Results Vireo Growth Accelerated Expansion with FLUENT Acquisition, Cementing its Florida Ambitions Aurora Cannabis Expanded Global Medical Portfolio with New International Product Launches Key Takeaways; Psychedelic Sector Silo Pharma Sees Momentum as U.S. Accelerates Psychedelic PTSD Treatments Helus Pharma Expanded Veteran […]
Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian‑based leading global medical cannabis company, is significantly expanding its global medical cannabis portfolio, with new product launches rolling out across
Aurora Cannabis Inc. outlook: improving international revenue, margins, and net cash. Valuation suggests 64% upside to $5.58. Click for more on ACB stock.
<body><p>STORY: Shares of cannabis firms reversed early gains on Thursday as investors took a closer look at the limited scope of the U.S. government's move to reclassify marijuana as a less-dangerous drug.</p><p>Cronos Group, Aurora Cannabis, Canopy Growth and Tilray Brands slumped between 7% and 15% in afternoon trading.</p><p>Shares of these companies had surged after Acting Attorney General Todd Blanche in a social media post said the Department of Justice was, quote, "immediately rescheduling FDA-approved marijuana and state-licensed marijuana from Schedule I to Schedule III." The department is also initiating an expedited hearing to consider the broader rescheduling of marijuana.</p><p>But industry insiders said the move stops short of a sweeping reclassification.</p><p>The CEO of FundCanna, which provides capital for cannabis companies, said the order applies specifically to FDA-approved cannabis drugs and products operating under state medical marijuana frameworks, rather than the broader market, creating uneven benefits across the sector.</p><p>A top executive at CB1 Capital Management added that the move was narrower than investors had hoped, rescheduling medical cannabis immediately while setting a June hearing on adult use...</p><p>with the market not understanding the, quote, "nuances involved, the opposition or the legal challenges." </p><p>Still, overall, the sector applauded the decision.</p><p>It would lift a major tax burden that is unique to the cannabis industry that had prevented some companies from claiming tax credits and writing off basic business expenses.</p><p>The reclassification could also ease access to funding as federal restrictions have long kept most banks and institutional investors on the sidelines, forcing cannabis producers to rely on costly loans or alternative lenders.</p></body>
Markets don’t usually wait for permission — they anticipate it. That’s why cannabis stocks jumped ahead of the official news that the Justice Dept. would reclassify marijuana from Schedule I to Schedule III. But here’s the real question investors should be asking: does this long-awaited shift actually change the investment case, or just the headlines? ... Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?
By Mrinalika Roy and Christy Santhosh April 23 (Reuters) - Shares of cannabis firms surged on Thursday after the U.S. government moved to reclassify the Food and Drug Administration-approved and state
Shares of Tilray Brands (NASDAQ:TLRY) are up roughly 10% in early Thursday trading, changing hands near $8.68 after the stock closed up 14% at $7.87 on Wednesday. The catalyst is growing speculation that the administration is preparing to reclassify marijuana to a less-dangerous drug category, a regulatory tailwind cannabis investors have been waiting on for ... Tilray Surges 10%: Rescheduling Momentum Builds as Traders Await Official Confirmation
Cannabis stocks are going â well â higher after the DEA issued an order to reschedule marijuana as a less-dangerous drug.
https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3aae122b1a91f8e4b6c690268
https://www.axios.com/2026/04/22/trump-marijuana-rule-change
Aurora Cannabis Inc. (NASDAQ:ACB) is one of the 10 best tobacco and cigarette stocks to invest in. As of April 15 closing, broader consensus sentiment around Aurora Cannabis Inc. (NASDAQ:ACB) was strongly bullish. The stock received coverage from 3 analysts, all of whom assigned Buy ratings. With a median 1-year target price of $6.68, it […]
Canada’s Aurora Cannabis (ACB) has bought privately held Safari Flower Co. in a stock-and-cash deal valued at $26.5 million as it looks for opportunities overseas.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks The deal includes a $2-million cash payment that is contingent on satisfaction of certain conditions. In a news release
Aurora Cannabis (ACB.TO) said Wednesday that it has acquired Safari Flower Company, a European certi
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| ACB | +3.45% | -2.96% | -14.69% | -32.08% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | +0.48% | +2.75% | -11.25% | -44.76% |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-06-11upcoming | -0.50 | — | — |
| 2026-02-04 | -0.08 | 0.03 | +135.29% |
| 2025-11-05 | -0.10 | -0.91 | -810.00% |
| 2025-08-06 | -0.02 | -0.27 | -1250.00% |
| 2025-06-18 | 0.13 | -0.43 | -430.77% |
| 2025-02-05 | -0.03 | 0.58 | +2209.09% |
| 2024-08-07 | -0.13 | 0.13 | +200.00% |
| 2024-06-20 | -0.20 | -0.59 | -194.60% |
| 2024-02-08 | -0.10 | -0.13 | -30.00% |
| 2023-11-09 | -0.50 | 0.14 | +127.90% |
| 2023-08-10 | -0.85 | -0.30 | +64.12% |
| 2023-06-14 | -0.95 | -1.80 | -89.42% |
| 2023-02-10 | -0.85 | -0.11 | +87.29% |
| 2022-11-10 | -1.27 | -0.72 | +43.19% |
| 2022-09-20 | -1.52 | -2.07 | -35.83% |
| 2022-05-12 | -2.14 | -2.20 | -2.96% |